Hodgkin's Lymphoma
News
Differences in IMRT Radiation Doses May Complicate Study Results in Lymphomas
(04/07/2008)
Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies in lymphomas difficult to interpret. These findings were reported in the Journal of the National Cancer Institute.
Hodgkin’s Lymphoma Survivors May Be at Risk for Secondary Cancer
(02/29/2008)
Hodgkin’s lymphoma survivors may be at risk for secondary cancer. These findings were recently reported in the British Journal of Cancer.
Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma
(02/05/2008)
A recent study compared lymphocyte-predominant Hodgkin’s lymphoma (LPHL) and classical Hodgkin’s lymphoma (cHL) in order to define differences in patient characteristics and possible treatment options for both types of disease. These results were published in the Journal of Clinical Oncology.
Annual Mammography Alone Not Sufficient for Young Hodgkin’s Survivors
(01/09/2008)
According to the results of a study published in the Annals of Oncology, annual screening mammography may miss some cases of early invasive breast cancer among young Hodgkin’s lymphoma survivors who were treated with supradiaphragmatic (above the diaphragm) radiation therapy.
Chemotherapy plus Radiation Recommended as Standard of Care in Early Hodgkin’s
(11/09/2007)
According to an article recently published in the New England Journal of Medicine, chemotherapy plus involved-field radiation should become the standard of care for early-stage Hodgkin’s disease.
More
Hodgkin's Lymphoma
Cancer News...